Trial intelligence / Profile preview

Endostar combined with chemoradiotherapy for esophageal cancer

ChiCTR-TRC-10001187Phase 4Completed

Sponsor
Fujian Medical University Cancer Hospital
Start
Dec 2010
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, open-label trial of endostar in esophageal cancer (2 arms), sponsored by Fujian Medical University Cancer Hospital. Primary endpoints: clinical safety and objective response rate. Started Dec 2010; status: completed.

02

Drugs

endostar
03

Conditions

esophageal cancer

Beyond the preview

Go deeper on ChiCTR-TRC-10001187.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-10001187.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call